GL1X · GenesisL1 explorer

Research workbench

Pinatuzumab Fab in complex with anti-kappa vhh domain

Analyse Pinatuzumab Fab in complex with anti-kappa vhh domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AND
Type
protein
Length
545 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti-kappa vhh domain; Pinatuzumab Fab heavy chain; Pinatuzumab Fab light chain
Pockets
6 · best druggability 0.76

Structure

x-ray diffraction · 3 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
KAnti-kappa vhh domainprotein1208% helix, 49% strand—
HPinatuzumab Fab heavy chainprotein2138% helix, 55% strand—
LPinatuzumab Fab light chainprotein2126% helix, 52% strand—

Ligands and binding sites

  • GOL · Glycerol · additive · chains K

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15210.760.8484empty
2590.560.9021empty
3950.560.8635empty
42870.540.7533empty
51380.460.7726empty

Interfaces

2 interfaces between chains.

  • H–L · 1777 Ų buried · 16 hydrogen bonds · protein-protein
  • K–L · 579 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6AND · Pinatuzumab Fab in complex with anti-Kappa VHH domain · the same entry in another collection · chain K against K, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.